The Ministry of Health, Labor and Welfare (MHLW) on December 18 presented a proposal to define the scope of products…
HOME > TOP STORIES
TOP STORIES
-
ACADEMIA Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study
September 9, 2014
-
BUSINESS All Eyes Glued to Japan Realignment after Mylan’s Buyout of Abbott’s Established Product Biz
September 8, 2014
-
BUSINESS MSD’s Januvia Logs 1st Sales Decline in Japan on Re-Pricing
September 5, 2014
-
BUSINESS US Court Backs Jury Verdict in Actos Suit, Orders Takeda to Pay US$6 Billion in Punitive Damages
September 5, 2014
-
REGULATORY Industry on Alert as Reformist Shiozaki Tapped as New Health Minister
September 4, 2014
-
REGULATORY Yasuhisa Shiozaki Tapped as New Health Minister
September 3, 2014
-
REGULATORY MOF Official Unami Urges Full-Scale NHI Price Revision upon Next Sales Tax Hike
September 2, 2014
-
BUSINESS Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs
September 1, 2014
-
BUSINESS Sanofi Greater China Head Baschiera to Shepherd Japan Unit
August 29, 2014
-
BUSINESS Roche Obtains First Refusal Right for All Chugai’s Products with Partial Amendment to Strategic Alliance Deal
August 29, 2014
-
REGULATORY Chuikyo Grants Unprecedented 60% Premium to Ono’s Opdivo
August 28, 2014
-
BUSINESS Otsuka Holdings Takes Aim at 915 Billion Yen Pharma Sales in FY2018 after Abilify Patent Loss
August 27, 2014
-
ORGANIZATION CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
August 27, 2014
-
REGULATORY PAFSC Second Committee to Review Nobelpharma’s Anticancer Drug Streptozocin on Sept. 5
August 26, 2014
-
BUSINESS Latuda Goes on Sale in UK: Sumitomo Dainippon
August 25, 2014
-
BUSINESS Pfizer Japan to Create New Unit for its Innovative Drug Business in December
August 22, 2014
-
ACADEMIA Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening
August 21, 2014
-
BUSINESS MTPC, AZ Ink Research Collaboration Deal in Diabetic Nephropathy
August 21, 2014
-
BUSINESS Japan to See Grueling Battle for Free-Price Viagra Generics
August 20, 2014
-
BUSINESS Pfizer Reveals First Doctor Payments amid Delays in Disclosure
August 19, 2014
ページ
Eli Lilly’s Kisunla (donanemab) will join the Japanese reimbursement list on November 20, with a health ministry panel giving the…
Will an “off-year” drug price revision happen in April 2025 or not? Over the last week, expectations have been up…
For 25 years, Morunda has been interviewing leaders in Japan’s pharmaceutical and medical device industry. Most country managers typically come from a commercial background, rooted in sales and marketing. It’s rare to find country managers who come from finance or…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…